Evaluation of Automatic Oxygen Flow Titration During Walking in Patients With COPD

NCT ID: NCT02150434

Last Updated: 2014-05-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-11-30

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the current study was to evaluate a new system (FreeO2) that automatically titrates oxygen flow to maintain stable SpO2, in patients with moderate or severe chronic obstructive pulmonary disease during exercise. The investigators hypothesized that continuous automatic adjustment of the oxygen flows during exercise would better maintain patients within the oxygenation target, reduce episodes of desaturation and hyperoxia and would improve walking exercise tolerance in comparison with fixed levels of low-flow oxygen and with compressed air breathing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD Exercise Endurance Shuttle Walking Test (Exercise at 85% of Maximal Shuttle Walking Test)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Compressed Air

compressed air delivered at a fixed flow of 2 L/min

Group Type SHAM_COMPARATOR

Compressed air

Intervention Type DRUG

compressed air delivered at a fixed flow of 2 L/min

Oxygen constant flow

oxygen delivered at a fixed flow of 2L/min

Group Type ACTIVE_COMPARATOR

Oxygen constant flow

Intervention Type DRUG

oxygen delivered at a fixed flow of 2L/min

Automated oxygen titration

oxygen at a variable flows delivered by the FreeO2

Group Type EXPERIMENTAL

Automated oxygen titration

Intervention Type DEVICE

Automated oxygen titration every second to maintain stable SpO2 at a predefined value (94% in the present study)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Automated oxygen titration

Automated oxygen titration every second to maintain stable SpO2 at a predefined value (94% in the present study)

Intervention Type DEVICE

Compressed air

compressed air delivered at a fixed flow of 2 L/min

Intervention Type DRUG

Oxygen constant flow

oxygen delivered at a fixed flow of 2L/min

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

FreeO2 system TM, Oxy'nov.inc Air Oxygen

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients older than 40 years
* Moderate to severe COPD according to the Global Initiative for Chronic Obstructive Lung Disease guidelines
* Who did not require long-term oxygen therapy were included in the study.
* Patients were also selected on the basis of known (end-exercise SpO2 \< 90% on a previous exercise test) or suspected (SpO2 \< 95% at rest) desaturation during exercise

Exclusion Criteria

* Episode of exacerbation or hospitalisation within last four weeks
* Current medical condition that could influence exercise tolerance
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fonds de la Recherche en Santé du Québec

OTHER_GOV

Sponsor Role collaborator

Canada Foundation for Innovation

OTHER

Sponsor Role collaborator

Laval University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

François Lellouche, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Centre de recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre de recherche de l'IUCPQ

Québec, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Lellouche F, L'Her E, Bouchard PA, Brouillard C, Maltais F. Automatic Oxygen Titration During Walking in Subjects With COPD: A Randomized Crossover Controlled Study. Respir Care. 2016 Nov;61(11):1456-1464. doi: 10.4187/respcare.04406. Epub 2016 Oct 18.

Reference Type DERIVED
PMID: 27794080 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FreeO2-Rehab-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.